Local intranasal immunotherapy for ragweed allergic rhinitis. II. Immunologic response

Area of Science:

• Immunology
• Allergy Research
• Otolaryngology

Background:

• Local nasal immunotherapy (LNIT) is a treatment approach for allergic rhinitis.
• Understanding the immunomodulatory effects of different immunotherapy formulations is crucial for optimizing treatment strategies.

Purpose of the Study:

• To evaluate the immunologic effects of unmodified ragweed extract (RW) and a glutaraldehyde polymer of ragweed extract (PRW) administered via local nasal immunotherapy.
• To compare the changes in serum and nasal secretory antibodies following RW and PRW treatments.

Main Methods:

• A double-blind, placebo-controlled study involving 67 subjects with ragweed allergy.
• Participants received either RW, PRW, or placebo intranasally.
• Serum ragweed-specific IgE (S-IgE), nasal secretory (NS-) IgE, secretory IgA (SIgA), IgG, and NS-albumin were measured.

Main Results:

• RW therapy significantly increased ragweed-specific S-IgE and NS-SIgA.
• PRW therapy significantly increased ragweed-specific NS-IgE, NS-IgG, and NS-SIgA.
• No significant changes were observed in ragweed-specific S-IgG across treatment groups.
• No consistent correlation was found between antibody levels and clinical symptom scores.

Conclusions:

• Both RW and PRW local nasal immunotherapy induced specific antibody responses.
• PRW demonstrated a more pronounced effect on nasal secretory antibodies, including IgE and IgG, compared to RW.
• Further research is needed to correlate these immunologic changes with clinical outcomes in patients undergoing LNIT.